Synapse - David Scheinberg

Results (499)

Cytarabine with a single high dose of idarubicin as induction therapy for adults with relapsed or refractory acute lymphoblastic leukemia (ALL)

Meeting Abstract

Weiss, M. A.; Aliff, T. B.; Tallman, M. S.; Frankel, S. R.; Kalaycio, M. E.; Maslak, P. G.; Scheinberg, D. A.; Roma, T. E.
Blood (2000)

Fulltext@MSK | Save

Synthetic analogue bcr/abl fusion peptides improve class I immunogenicity to the native protein

Meeting Abstract

Pinilla-Ibarz, J.; Korontvitz, T.; Roberts, W.; Shaed, S.; Cathcart, K.; Scheinberg, D. A.
Blood (2000)

Fulltext@MSK | Save

Phase I study of a single high dose of liposomal daunorubicin combined with high dose cytarabine for adult patients with relapsed/refractory acute myelogenous leukemia (AML)

Meeting Abstract

Maslak, P.; Weiss, M.; Jurcic, J.; Cathcart, K.; Heaney, M.; Berman, E.; Soignet, S.; Scheinberg, D.; Ward, S.
Blood (2000)

Fulltext@MSK | Save

Vaccination with CD20 peptide conjugates induces a biologically active, specific immune response in mice

Meeting Abstract

Roberts, W. K.; Agus, D.; Pinilla-Ibarz, J.; Zelenetz, A.; Livingston, P. O.; Scheinberg, D. A.
Blood (2000)

Fulltext@MSK | Save

Vaccination of CML patients with a p210-derived peptide vaccine plus QS-21 and GM-CSF

Meeting Abstract

Bocchia, M.; Marconcini, S.; Birtolo, S.; Raspadori, D.; Bucalossi, A.; Amabile, M.; Scheinberg, D. A.; Lauria, F.
Blood (2000)

Fulltext@MSK | Save

Use of a histone deacetylase inhibitor to optimize the induction of a leukemia-specific cytotoxic T-cell response by dendritic cells derived from AML blasts